Comparison of MRI and sonography in the preliminary evaluation for fibroid embolization.

OBJECTIVE: The purpose of our study was to evaluate whether pelvic MRI provides additional clinically relevant information after sonography in the preprocedure evaluation of uterine artery embolization of fibroids. MATERIALS AND METHODS: Forty-nine women who presented for consultation for uterine artery embolization were retrospectively reviewed. The MRI and sonography scans were independently evaluated and compared for uterine size, fibroid size and location (categorized as paraendometrial, intramural, subserosal, or pedunculated) of the four largest fibroids in each patient, and the total number of fibroids present. RESULTS: One hundred twenty-two fibroids were measured. The uterine volume was significantly smaller as measured on MRI compared with sonography (p = 0.01). We found good MRI and sonography correlation of the volume of the single largest fibroid in each patient (R = 0.87) but poor correlation of fibroid location (R = 0.17). MRI detected 31 paraendometrial fibroids and three pedunculated fibroids that were thought to be intramural fibroids on sonography. Five fibroids thought to be paraendometrial on sonography were confirmed to be subserosal or intramural on MRI. Discrepancy in the total number of fibroids was noted, with additional fibroids found on MRI in 31 of 49 patients and erroneously suspected on sonography in five of 49 patients. Pelvic MRI affected management in 11 of 49 patients, leading to cancellation of uterine artery embolization in four patients. In another seven patients who were originally thought to be poor candidates on the basis of sonographic findings, uterine artery embolization was performed. MRI did not alter the management plan in 38 patients. CONCLUSION: MRI provided considerable additional information compared with sonography and affected clinical decision making in a substantial number of patients. MRI should be considered in all patients being evaluated for uterine artery embolization.

Sonographic evaluation of spleen size in tall healthy athletes.

OBJECTIVE: The purpose of this study was to establish the range of spleen sizes in tall healthy athletes. SUBJECTS AND METHODS: Sonographic measurements of spleen size and left renal length were performed on 129 college athletes (82 men, 47 women). Length, width, and thickness of the spleen and left renal length were obtained. In addition, the height, weight, and age of each athlete were recorded. Pearson's product moment correlation coefficients were calculated, and linear regression analysis was used to create a model for calculating normative values. RESULTS: The mean body height for men was 74.3 (189 cm) +/-(SD) 3.7 inches (9 cm) and for women was 69.3 (176 cm) +/- 3.7 inches (9 cm). Spleen length was greater than 12 cm in 31.7% of the men (mean spleen length, 11.4 +/- 1.7 cm) and in 12.8% of the women (mean spleen length, 10.3 +/- 1.3 cm). In women, height correlated with spleen length (r = 0.3, p = 0.05), width (r = 0.4, p = 0.01), and volume (r = 0.3, p = 0.02) but not with thickness (r = 0.08, p = 0.6). Spleen length did correlate with left renal length (r = 0.5, p = 0.0005). In men, height correlated with spleen length (r = 0.4, p = 0.0003), width (r = 0.5, p = 0.0001), and volume (r = 0.4, p = 0.0002) and less with thickness (r = 0.3, p = 0.01). Spleen length and left renal length were poorly correlated (r = 0.2, p = 0.04). Regression analysis showed that in women taller than 5 ft 6 inches (168 cm), the mean splenic length of 10 cm increased by 0.1 cm for each 1-inch incremental increase in height. In men taller than 6 ft (180 cm), the mean splenic length of 11 cm increased by 0.2 cm for each 1-inch incremental increase in height. CONCLUSION: Spleen size correlates with height in tall healthy athletes. Nomograms from this data can be used to gauge the risk of returning to play after episodes of acute splenomegaly, as with infectious mononucleosis.

Liver imaging with multidetector helical computed tomography.

The speed and flexibility of multidetector computed tomography (MDCT) have led to improvements in liver imaging, particularly related to the detection and characterization of focal lesions. This report discusses the different phase of liver enhancement following the bolus administration of iodinated contrast material, and the enhancement pattern of various liver lesions during these phases. We also propose guidelines for designing protocols for MDCT of the liver and discuss the principles of contrast media delivery.

Liver imaging with MDCT and high concentration contrast media.

Liver imaging has advanced greatly over the last 10 years with helical CT capability and more recently the addition of multidetector-row CT (MDCT). Multidetector CT technology facilitates imaging at faster speeds with improved image quality and less breathing artifact [Abdom. Imaging 25 (2000) 643]. Exquisite three-dimensional data sets can be obtained with thin collimation providing improved lesion detection, multiplanar imaging, and the ability to perform CT angiography of the liver and mesenteric vessels. New challenges arise with this advance in technology including safety considerations. The radiation dose to the patient has increased with MDCT and this is compounded by the ability to perform multi-phase liver imaging. Furthermore, issues of contrast media administration require reconsideration including optimal timing and rate of administration, the total volume of contrast needed and the ideal iodine concentration of the contrast media. Recently, the use of high concentration contrast media (HCCM) has been explored and study results to date will be reviewed.

Liver: single breath-hold dynamic subtraction CT with multi-detector row helical technology feasibility study.

Fifty-two patients with known or suspected hypervascular malignancy were examined to determine the technical feasibility of performing single-breath-hold dynamic subtraction computed tomography (CT) of the liver with multi-detector row helical CT. The precontrast and hepatic arterial CT scans, which were acquired during the same breath hold, were subtracted. The mean liver-to-muscle contrast ratio on the precontrast, hepatic arterial, and subtracted images was 1.3, 1.4, and 2.3, respectively. In 13 patients with lesions, the subtracted images showed a 2.5-fold increase in mean lesion contrast compared with the hepatic arterial CT scans.

Pseudoenhancement of simple renal cysts: a comparison of single and multidetector helical CT.

PURPOSE: The purpose of this work was to compare the extent of pseudoenhancement (artifactual increase in measured attenuation of a simple cyst after contrast medium administration) in a phantom model on single detector and multidetector helical CT scanners. METHOD: The phantom consisted of four water-filled spheres varying in size from 8 to 28 mm, suspended in an aqueous contrast medium bath. Iodine concentration in the bath was varied: 0, 6, 12, and 24 mg/ml corresponding to attenuation values of 0, +108, +180, and +300 HU. The phantom was scanned on single detector and multidetector helical CT scanners during the same session. Collimation (1, 3, and 5 mm) and pitch (1 and 1.5:1, single detector; 3:1 and 6:1, multidetector) were varied at each concentration. All scans were performed at 140 kVp and 170 mA. The region of interest was measured at the center of each sphere. The effects were analyzed using a linear regression model. RESULTS: The degree of pseudoenhancement was more pronounced with increasing iodine concentration, decreasing cyst size, and wider collimation (all p = 0.0001). Pseudoenhancement was also more marked on the multidetector than the single detector scanner (p = 0.0001). At physiological levels of renal enhancement, the average pseudoenhancement was +18 HU for the single detector versus +23 HU for the multidetector scanner. Variation in pitch had no effect. CONCLUSION: Pseudoenhancement is greater on a multidetector than a single detector helical CT scanner and may exceed 20 HU at physiological levels of renal enhancement.